Skip to content

Comparison of the effects of Atropine and Tetracaine on Oculo Cardiac Reflex (OCR) in strabismus surgery

Comparison of the effectiveness of preoperative administration of intravenous Atropine and topical Tetracaine on the incidence and severity of Oculo Cardiac Reflex (OCR) in strabismus surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150106020588N8
Enrollment
120
Registered
2022-08-13
Start date
2018-04-21
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strabismus. Other strabismus

Interventions

Intervention 1: Intervention group 1: Patients in this group after inducting of anesthesia using 5 mg/kg of Thiopental sodium manufactured by Elixir Company, an amount of 0.5 mg/kg of Atracurium manuf

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 70 Years

Inclusion criteria

Inclusion criteria: Candidate for Strabismus surgery Age 10 to 70 years ASA class I and II informed consent to enter the study

Exclusion criteria

Exclusion criteria: Allergic to Atropine, Tetracaine and artificial tears Cardiovascular diseases history

Design outcomes

Primary

MeasureTime frame
Heart Rate. Timepoint: Before induction, immediately after the induction of anesthesia and then every 5 minutes to 30 minutes, and then every 10 minutes until the end of the surgery. Method of measurement: ECG monitoring.;Blood Pressure. Timepoint: Before induction, immediately after the induction of anesthesia and then every 5 minutes to 30 minutes, and then every 10 minutes until the end of the surgery. Method of measurement: Sphygmomanometer.

Secondary

MeasureTime frame
Surgery Duration. Timepoint: From the moment of surgical intervention to the end of eye dressing. Method of measurement: Timer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDariush Moradi Farsani

Esfahan University of Medical Sciences

dmoradi@med.mui.ac.ir+98 31 3668 8597

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026